Who are you looking for?

Install Famoose

Keep Famoose on your home screen or desktop for easy access.

Open this site in Chrome or Edge and look for Install app in the browser menu or address bar. If no install option appears, you can bookmark Famoose instead.

Famoose.co
Appearance
Text size
Page width
Colour
HPV vaccination

Development of HPV vaccination

Vaccines targeting human papillomavirus created a means to prevent infections that cause cervical and other cancers.

When
2006 and subsequent introduction
Where
International research and vaccination programmes
Gardasil vaccine and packaging; a product image rather than a photograph of the original research.
Gardasil vaccine and packaging; a product image rather than a photograph of the original research.

Vaccines targeting human papillomavirus created a means to prevent infections that cause cervical and other cancers.

01

Background

Connecting a virus to cancer

Evidence that certain HPV types cause cervical cancer changed prevention research. Scientists sought a vaccine that would prepare the immune system without exposing recipients to the virus's cancer-causing machinery. Work on virus-like particles supplied a practical route.[2]

02

What happened

  1. 1990s–2006

    Research becomes a licensed vaccine

    University, public-sector and commercial teams contributed to the technology and trials. The first HPV vaccine was licensed in 2006. Treating the outcome as the work of one company or one scientist would omit the accumulated research that made it possible.[3]

03

Impact & evidence

Prevention, not treatment

Blocking infection before disease develops

The vaccines prevent infection with targeted HPV types and the associated precancerous changes. They do not remove every cause of cervical cancer or treat an infection already established. Their significance is the ability to intervene before a cancer-causing pathway begins.[2]

04

Aftermath & legacy

A scientific advance with unequal reach

Countries introduced programmes at different speeds, with cost, delivery systems and public confidence influencing uptake. Later evidence of reduced precancer and cancer strengthened the original trial findings. The history therefore includes both vaccine development and the challenge of making prevention available where cervical cancer causes the greatest burden.[1]

Sources & image credits (3)
  1. Wikipedia — HPV vaccine ↗
  2. US National Cancer Institute: developing HPV vaccines ↗
  3. National Cancer Institute: the HPV vaccine research landmark ↗

Jan Christian @ www.ambrotosphotography.com Gardasil_vaccine_and_box.jpg : Jan Christian @ www.ambrotosphotography.com Image source ↗

Related historical cases